This is a Validated Antibody Database (VAD) review about rat anaplastic lymphoma kinase, based on 4 published articles (read how Labome selects the articles), using anaplastic lymphoma kinase antibody in all methods. It is aimed to help Labome visitors find the most suited anaplastic lymphoma kinase antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
anaplastic lymphoma kinase synonym: ALK tyrosine kinase receptor; anaplastic lymphoma kinase; anaplastic lymphoma receptor tyrosine kinase

Santa Cruz Biotechnology
mouse monoclonal
  • western blot; mouse; loading ...; fig 3a
Santa Cruz Biotechnology anaplastic lymphoma kinase antibody (Santa Cruz Biotechnology, Inc, sc-398791) was used in western blot on mouse samples (fig 3a). Int J Oncol (2018) ncbi
mouse monoclonal
  • western blot; human; 1:100; loading ...; fig 8c
Santa Cruz Biotechnology anaplastic lymphoma kinase antibody (Santa Cruz Biotechnology Inc, c-398791) was used in western blot on human samples at 1:100 (fig 8c). Sci Transl Med (2017) ncbi
Cell Signaling Technology
rabbit polyclonal
  • western blot; human; loading ...; fig 2e
Cell Signaling Technology anaplastic lymphoma kinase antibody (Cell Signaling, 3983) was used in western blot on human samples (fig 2e). Oncotarget (2018) ncbi
rabbit polyclonal
  • western blot; human; fig 1b
Cell Signaling Technology anaplastic lymphoma kinase antibody (Cell Signaling, 3983) was used in western blot on human samples (fig 1b). Cancer Res (2017) ncbi
Articles Reviewed
  1. Liu S, Wang F, Liu G. Knockdown of pleiotrophin increases the risk of preeclampsia following vitrified-thawed embryo transfer. Int J Oncol. 2018;53:1847-1856 pubmed publisher
  2. Pilling A, Kim J, Estrada Bernal A, Zhou Q, Le A, Singleton K, et al. ALK is a critical regulator of the MYC-signaling axis in ALK positive lung cancer. Oncotarget. 2018;9:8823-8835 pubmed publisher
  3. Zeng L, Kang R, Zhu S, Wang X, Cao L, Wang H, et al. ALK is a therapeutic target for lethal sepsis. Sci Transl Med. 2017;9: pubmed publisher
  4. Vaishnavi A, Schubert L, Rix U, Marek L, Le A, Keysar S, et al. EGFR Mediates Responses to Small-Molecule Drugs Targeting Oncogenic Fusion Kinases. Cancer Res. 2017;77:3551-3563 pubmed publisher